{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:57:16Z","timestamp":1790362636220,"version":"4.1.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/fpc.0b013e32831a6a3a","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T03:15:25Z","timestamp":1228792525000},"page":"67-76","source":"Crossref","is-referenced-by-count":45,"title":["Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder"],"prefix":"10.1097","volume":"19","author":[{"given":"Henricus G.","family":"Ruh\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Ooteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Moeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aart H.","family":"Schene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R2-7-20210212","first-page":"86","article-title":"Imaging the serotonin transporter during major depressive disorder and antidepressant treatment","volume":"32","author":"Meyer","year":"2007","journal-title":"J Psychiatry Neurosci"},{"key":"R3-7-20210212","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00259-005-1912-y","article-title":"Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study","volume":"32","author":"Erlandsson","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-7-20210212","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","article-title":"Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study","volume":"161","author":"Meyer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R5-7-20210212","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpsyc.60.4.386","article-title":"High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography","volume":"60","author":"Suhara","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R6-7-20210212","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-005-0304-0","article-title":"A dose-finding study of duloxetine based on serotonin transporter occupancy","volume":"185","author":"Takano","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R7-7-20210212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-002-1218-8","article-title":"Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [11C]McN 5652","volume":"164","author":"Kent","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"R8-7-20210212","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1176\/appi.ajp.158.11.1843","article-title":"Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [11C]DASB PET imaging study","volume":"158","author":"Meyer","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R9-7-20210212","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-006-0540-y","article-title":"Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a [123I]-ADAM SPECT study","volume":"189","author":"Catafau","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R10-7-20210212","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.npp.1300036","article-title":"Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration","volume":"28","author":"Kugaya","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R11-7-20210212","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.biopsych.2004.07.001","article-title":"Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors","volume":"56","author":"Kugaya","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R12-7-20210212","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1515\/CCLM.2004.243","article-title":"Therapeutic drug monitoring of non-tricyclic antidepressant drugs","volume":"42","author":"Mitchell","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R14-7-20210212","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.pnpbp.2005.03.012","article-title":"Pharmacogenetics of the serotonin transporter","volume":"29","author":"Lesch","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R15-7-20210212","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0006-3223(99)00171-7","article-title":"A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity","volume":"47","author":"Heinz","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R16-7-20210212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/syn.10204","article-title":"No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET","volume":"48","author":"Shioe","year":"2003","journal-title":"Synapse"},{"key":"R17-7-20210212","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1176\/appi.ajp.161.3.525","article-title":"Central serotonin transporter availability measured with [123I]\u03b2-CIT SPECT in relation to serotonin transporter genotype","volume":"161","author":"Van Dyck","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R18-7-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(00)01123-9","article-title":"No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism","volume":"50","author":"Willeit","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R19-7-20210212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.mp.4001405","article-title":"A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety","volume":"9","author":"Schinka","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R20-7-20210212","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajmg.b.20158","article-title":"Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits","volume":"127","author":"Sen","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R21-7-20210212","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"R22-7-20210212","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00041444-200409000-00001","article-title":"Meta-analysis of serotonin transporter polymorphisms and affective disorders","volume":"14","author":"Lotrich","year":"2004","journal-title":"Psychiatr Genet"},{"key":"R23-7-20210212","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.1071829","article-title":"Serotonin transporter genetic variation and the response of the human amygdala","volume":"297","author":"Hariri","year":"2002","journal-title":"Science"},{"key":"R24-7-20210212","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archpsyc.62.2.146","article-title":"A susceptibility gene for affective disorders and the response of the human amygdala","volume":"62","author":"Hariri","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R25-7-20210212","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/mi.4.2.8","article-title":"Serotonin transporter: gene, genetic disorders, and pharmacogenetics","volume":"4","author":"Murphy","year":"2004","journal-title":"Mol Interv"},{"key":"R26-7-20210212","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nn1463","article-title":"5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression","volume":"8","author":"Pezawas","year":"2005","journal-title":"Nat Neurosci"},{"key":"R27-7-20210212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R28-7-20210212","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/503850","article-title":"Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder","volume":"78","author":"Hu","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R29-7-20210212","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1176\/appi.ajp.163.1.48","article-title":"Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain","volume":"163","author":"Parsey","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R30-7-20210212","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biopsych.2006.09.022","article-title":"Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [11C] DASB positron emission tomography study","volume":"62","author":"Praschak-Rieder","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R31-7-20210212","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00702-006-0609-0","article-title":"Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype","volume":"114","author":"Reimold","year":"2007","journal-title":"J Neural Transm"},{"key":"R32-7-20210212","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archpsyc.64.7.783","article-title":"Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression","volume":"64","author":"Hu","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R33-7-20210212","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2006.07.017","article-title":"Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample","volume":"61","author":"Kraft","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R35-7-20210212","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0197-4580(00)00152-4","article-title":"Age-related decline in central serotonin transporter availability with [123I]\u03b2-CIT SPECT","volume":"21","author":"Van Dyck","year":"2000","journal-title":"Neurobiol Aging"},{"key":"R37-7-20210212","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R38-7-20210212","first-page":"883","article-title":"Assessing the feasibility of using computerized pharmacy refill data to monitor antidepressant treatment on a population basis: a comparison of automated and self-report data","volume":"51","author":"Saunders","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R39-7-20210212","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-3956(99)00037-0","article-title":"The responsiveness of the hamilton depression rating scale","volume":"34","author":"Faries","year":"2000","journal-title":"J Psychiatr Res"},{"key":"R40-7-20210212","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.comppsych.2005.03.001","article-title":"Clinical use of the Hamilton depression rating scale: is increased efficiency possible? A post hoc comparison of Hamilton depression rating scale, Maier and Bech subscales, clinical global impression, and symptom checklist-90 scores","volume":"46","author":"Ruhe","year":"2005","journal-title":"Compr Psychiatry"},{"key":"R41-7-20210212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The inventory of depressive symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol Med"},{"key":"R42-7-20210212","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.npp.1300683","article-title":"Validation of [123I]\u03b2-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram","volume":"30","author":"De Win","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"R43-7-20210212","first-page":"36","article-title":"Imaging serotonin and dopamine transporters with [123I]\u03b2-CIT SPECT: binding kinetics and effects of normal aging","volume":"41","author":"Pirker","year":"2000","journal-title":"J Nucl Med"},{"key":"R44-7-20210212","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-3223(88)90198-9","article-title":"Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites","volume":"24","author":"Laruelle","year":"1988","journal-title":"Biol Psychiatry"},{"key":"R45-7-20210212","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"R46-7-20210212","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R47-7-20210212","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-2999(91)90599-L","article-title":"Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT","volume":"200","author":"Innis","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"R48-7-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/syn.890130402","article-title":"SPECT imaging of dopamine and serotonin transporters with [123I]\u03b2-CIT: pharmacological characterization of brain uptake in nonhuman primates","volume":"13","author":"Laruelle","year":"1993","journal-title":"Synapse"},{"key":"R49-7-20210212","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0006-3223(01)01283-5","article-title":"Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome","volume":"51","author":"Rausch","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R50-7-20210212","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.mp.4000698","article-title":"The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants","volume":"5","author":"Nakamura","year":"2000","journal-title":"Mol Psychiatry"},{"key":"R51-7-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.ypg.0000218611.53064.a0","article-title":"Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants","volume":"16","author":"Smeraldi","year":"2006","journal-title":"Psychiatr Genet"},{"key":"R52-7-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpsyc.63.9.978","article-title":"Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls","volume":"63","author":"Neumeister","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R53-7-20210212","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0893-133X(00)00132-9","article-title":"Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression","volume":"23","author":"Pollock","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"R54-7-20210212","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.pnpbp.2007.05.018","article-title":"Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder","volume":"31","author":"Kang","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R55-7-20210212","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/archpsyc.61.11.1163","article-title":"Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression","volume":"61","author":"Murphy","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R56-7-20210212","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.pnpbp.2005.03.013","article-title":"The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments","volume":"29","author":"Serretti","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R57-7-20210212","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1523\/JNEUROSCI.19-23-10494.1999","article-title":"Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level","volume":"19","author":"Benmansour","year":"1999","journal-title":"J Neurosci"},{"key":"R58-7-20210212","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1523\/JNEUROSCI.22-15-06766.2002","article-title":"Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter","volume":"22","author":"Benmansour","year":"2002","journal-title":"J Neurosci"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01213011-200901000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:33:27Z","timestamp":1786037607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-200901000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32831a6a3a","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}